3-Hydroxy Repaglinide d5 (Mixture of Diastereomers)

3-Hydroxy Repaglinide d5 (Mixture of Diastereomers) is a medication that is commonly used in the treatment of type 2 diabetes. It is a mixture of diastereomers, which are stereoisomers that are not mirror images of each other. This medication works by stimulating the release of insulin from the pancreas, which helps to lower blood sugar levels in the body. The chemical formula for 3-Hydroxy Repaglinide d5 is C27H33D5NO4, and it has a molecular weight of 447.63 g/mol. This medication is typically administered orally in the form of a tablet. It is absorbed quickly by the body and reaches peak concentrations within 1 hour of administration. The most common side effects of 3-Hydroxy Repaglinide d5 include hypoglycemia (low blood sugar levels), headache, and nausea. It is important to monitor blood sugar levels regularly while taking this medication to avoid hypoglycemia. This medication should be used with caution in patients with liver or kidney disease, as it is metabolized by the liver and excreted by the kidneys. It should also be avoided in pregnant or breastfeeding women, as its effects on fetal development and milk production are not yet fully understood. In conclusion, 3-Hydroxy Repaglinide d5 (Mixture of Diastereomers) is a medication that is commonly used in the treatment of type 2 diabetes. Its chemical formula and molecular weight are C27H33D5NO4 and 447.63 g/mol, respectively. This medication works by stimulating the release of insulin from the pancreas to lower blood sugar levels in the body. While it is generally safe and effective, it should be used with caution in patients with liver or kidney disease and avoided in pregnant or breastfeeding women.